cccDNA
环状DNA
生物
HBx公司
乙型肝炎病毒β前体
细胞内
DNA病毒
DNA
乙型肝炎病毒
乙型肝炎病毒DNA聚合酶
病毒学
遗传学
病毒
基因
基因组
乙型肝炎表面抗原
作者
Liudi Tang,Ping An,Qiong Zhao,Cheryl Ann Winkler,Jinhong Chang,Ju‐Tao Guo
出处
期刊:Journal of Virology
[American Society for Microbiology]
日期:2022-12-15
卷期号:97 (1): e0126122-e0126122
被引量:4
摘要
Elimination or functional inactivation of cccDNA minichromosomes in HBV-infected hepatocytes is essential for the cure of chronic hepatitis B virus (HBV) infection. However, lack of knowledge of the molecular mechanisms of cccDNA metabolism and regulation hampers the development of antiviral drugs to achieve this therapeutic goal. Our findings reported here imply that enhanced cccDNA amplification may occur under selected pathobiological conditions, such as cellular stress, to subvert the dilution or elimination of cccDNA and maintain the persistence of HBV infection. Therapeutic inhibition of HSPA1-enhanced cccDNA amplification under these pathobiological conditions should facilitate the elimination of cccDNA and cure of chronic hepatitis B.
科研通智能强力驱动
Strongly Powered by AbleSci AI